A detailed history of Dn B Asset Management As transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 6,072 shares of AXSM stock, worth $568,764. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,072
Previous 4,426 37.19%
Holding current value
$568,764
Previous $353,000 38.24%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

BUY
$65.72 - $80.5 $108,175 - $132,503
1,646 Added 37.19%
6,072 $488,000
Q1 2024

Apr 12, 2024

BUY
$69.39 - $97.64 $307,120 - $432,154
4,426 New
4,426 $353,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.02B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.